Free Cash Flow

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

After a stock plunge, Yext offers to buy back shares at a premium, signaling deep undervaluation and creating a critical choice for its investors.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

The Baltic real estate giant divests a key Latvian asset at a profit, unlocking millions in capital for new investments and signaling a hot logistics market.

Cloud communications firm RingCentral will join the S&P SmallCap 600, triggering investment shifts and highlighting tech's growing market influence.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Natural Gas Services Group affirms its dividend, a sign of strength. But what does this payout reveal about its financial health and the booming gas market?

NineDot Energy's massive financing deal will build 28 battery storage sites, boosting grid resilience, aiding low-income families, and cleaning the air.

With the AI services market heating up, Bitwise appoints Sarith Sabarinath to sharpen its narrative and drive global growth. Here's why the move is critical.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

Guardforce AI aims to acquire a leading speech therapy platform, signaling a major strategic pivot from secured logistics to the booming AI healthcare market.

The private jet operator posted record revenue with fewer planes, achieving its first-ever quarter of positive Adjusted EBITDA in a major turnaround.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Tandy Leather clarifies a key date for its large $0.75 special dividend. Learn what the unusual timing means for investors and what it signals about the company.

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

Copper Intelligence debuts on the US market, securing a high-grade DRC copper asset amid a global shortage and a new US push for critical minerals.

The fragrance giant affirmed its $0.20 quarterly dividend, signaling stability to investors even as it navigates shifting consumer habits and a tough market.

With a new celebrity ad, CoreWeave is making a play for AI dominance. But can its specialized tech overcome financial risks and challenge industry giants?